HB 2163 creates a program for nonviolent offenders with serious substance abuse issues (who haven't been convicted of a dangerous felony) to receive treatment instead of immediate incarceration. Eligible offenders undergo 12-24 months of institutional drug/alcohol treatment, with their sentence suspended until program completion. Upon successful completion, participants may petition their sentencing court for limited driving privileges to access work, school, medical care, or treatment programs. The bill replaces three existing Missouri law sections to establish this treatment pathway and driving privilege process.
HB 2296 requires health insurance plans in Missouri to cover nonopioid medications for acute pain without discrimination. It prohibits insurers from denying coverage for nonopioid drugs, forcing patients to try opioids first, or charging higher out-of-pocket costs for nonopioid options when prescribed by a licensed provider for pain expected to last 30 days or less. The law applies to all health benefit plans issued or renewed on or after January 1, 2027, directly affecting insurance companies and enrollees (policyholders) seeking pain treatment. This creates a clear standard for coverage of nonopioid alternatives to opioids for short-term pain management.
SB 1449 would require health insurance plans to cover non-opioid alternatives for pain management, such as physical therapy or certain medications. This bill directly affects insurance companies, which would need to provide this coverage, and patients seeking pain treatment without opioids. The key provision mandates that insurers treat these non-opioid options with the same coverage terms as opioid medications. The bill aims to expand access to safer pain management options through insurance coverage.
HB 1966 requires health insurance plans in Missouri to cover nonopioid medications for acute pain (pain expected to last 30 days or less) on the same terms as opioids. It prohibits insurers from denying coverage for nonopioid drugs, forcing patients to try opioids first, or charging higher out-of-pocket costs for nonopioid options. The law directly affects patients (enrollees) and health insurance plans, ensuring equal treatment for nonopioid alternatives when prescribed by licensed providers. It takes effect for all new or renewed health benefit plans on or after January 1, 2027.
SB 1151, the "End Hospital Institutionalization Act," prevents hospitals from keeping medically stable patients unnecessarily in emergency rooms or inpatient settings ("boarding") when community care options are unavailable. It requires juvenile courts to act immediately for children under their jurisdiction or not under court care, and directs the Department of Mental Health to provide case management and treatment (including residential care) for adults with developmental disabilities, serious mental illness, or substance use disorders. Hospitals must notify the relevant authorities when boarding occurs, and the state will reimburse hospitals for boarding costs after notification. This law aims to move patients from hospitals to appropriate community-based care settings without delay.
HB 1680 requires health insurance plans to cover nonopioid medications equally to opioids for treating acute pain (short-term pain from injury or illness expected to last 30 days or less). It prohibits insurers from denying coverage for nonopioid drugs, forcing patients to try opioids first, or charging higher copays for nonopioid options compared to opioids. This directly affects health insurance plans and their enrollees (policyholders) who need pain treatment. The law applies to all health benefit plans issued or renewed on or after January 1, 2027. The bill aims to expand access to nonopioid pain management by removing financial and procedural barriers in insurance coverage.
HB 2231 requires facilities advertising dual diagnosis treatment (addressing both substance use disorders and mental health conditions) to meet specific operational standards. It mandates medication management systems for tracking prescriptions, regular patient reviews, and education; requires integrated, evidence-based treatment plans tailored to individual patients; and prohibits misleading advertising claims about services or licensure. Facilities must clearly disclose their credentials in all marketing materials. The Department of Mental Health enforces these rules, with violations subject to penalties under existing licensing laws. This bill directly affects all treatment centers in the state that market themselves as providing dual diagnosis care.
SB 1024 limits initial opioid prescriptions for acute pain to a seven-day supply, requiring doctors to discuss risks and non-opioid alternatives with patients before prescribing. It sets supply limits (30 days for stronger opioids, 90 days for others) and protects pharmacists who follow these rules. The bill applies to most patients but excludes those receiving cancer treatment, hospice care, long-term facility care, or substance abuse treatment. Key provisions aim to reduce opioid overprescribing while ensuring access for specific medical needs.
SB 1350 requires health insurance plans in Missouri to cover non-opioid medications for acute pain without restrictions, effective January 1, 2027. It directly affects enrollees (insurance policyholders) prescribed non-opioid drugs for pain expected to last 30 days or less. The bill prohibits insurers from denying coverage for these medications, forcing patients to try opioids first, or charging higher out-of-pocket costs for non-opioid drugs compared to opioids. This applies to all health benefit plans issued or renewed after the effective date, aiming to expand access to non-opioid pain treatment options.
